You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

List of Excipients in API PAZOPANIB HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing PAZOPANIB HYDROCHLORIDE

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	VOTRIENT	pazopanib hydrochloride	0078-0670	CELLULOSE, MICROCRYSTALLINE
Novartis Pharmaceuticals Corporation	VOTRIENT	pazopanib hydrochloride	0078-0670	FERROSOFERRIC OXIDE
Novartis Pharmaceuticals Corporation	VOTRIENT	pazopanib hydrochloride	0078-0670	HYPROMELLOSES
Novartis Pharmaceuticals Corporation	VOTRIENT	pazopanib hydrochloride	0078-0670	MAGNESIUM STEARATE
Novartis Pharmaceuticals Corporation	VOTRIENT	pazopanib hydrochloride	0078-0670	POLYETHYLENE GLYCOL 400
Novartis Pharmaceuticals Corporation	VOTRIENT	pazopanib hydrochloride	0078-0670	POLYSORBATE 80
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing PAZOPANIB HYDROCHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC	Excipient
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022	CELLULOSE, MICROCRYSTALLINE
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022	FERRIC OXIDE YELLOW
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022	FERROSOFERRIC OXIDE
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022	HYPROMELLOSE 2910
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022	MAGNESIUM STEARATE
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022	POLYETHYLENE GLYCOL 400
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for PAZOPANIB HYDROCHLORIDE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

PAZOPANIB HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

PAZOPANIB HYDROCHLORIDE drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

PAZOPANIB HYDROCHLORIDE drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE 2910

PAZOPANIB HYDROCHLORIDE drug variants containing HYPROMELLOSE 2910

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2910

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSES

PAZOPANIB HYDROCHLORIDE drug variants containing HYPROMELLOSES

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing HYPROMELLOSES

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

PAZOPANIB HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 400

PAZOPANIB HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

PAZOPANIB HYDROCHLORIDE drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE

PAZOPANIB HYDROCHLORIDE drug variants containing POVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing POVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE K30

PAZOPANIB HYDROCHLORIDE drug variants containing POVIDONE K30

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing POVIDONE K30

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

PAZOPANIB HYDROCHLORIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE A

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

PAZOPANIB HYDROCHLORIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

PAZOPANIB HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pazopanib hydrochloride	0078-0670
Novugen Pharma (USA) LLC	pazopanib hydrochloride	82293-022
>Company	>Ingredient	>NDC

PAZOPANIB HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.